Cardiac Rhythm Management Devices | Market Insights | US | 2020
The mature US CRM device market will remain fairly flat through 2028, seeing rising ICM procedure volumes and the adoption of premium-priced innovative products offset by flat pulse generator sales and price erosion. Despite the overall CRM market seeing minimal growth, the rapid adoption of new products like leadless pacemakers and S-ICDs highlights the enormous opportunity for innovation, as well as both revenue and market share gains. However, the COVID-19 global pandemic will have a significant impact on the US CRM device market, resulting in lost procedure volumes in the short term followed by a period of recovery.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the US cardiac rhythm management device market across a 10-year period.
